Built for Success at Scale: Inside Simtra's Integrated CDMO Model

Sponsored by Simtra BioPharma Solutions

Simtra BioPharma Solutions stands out in the CDMO landscape through its unwavering focus on sterile injectable delivery platforms and 65 years of accumulated expertise in this specialized field. Rich Kennedy, senior director of business development, walks viewers through what defines Simtra's approach: a purpose-driven organization that puts patients first, clients at the center of decision-making, and partners with manufacturers for the full lifecycle of their products—not just individual projects. Kennedy emphasizes that this deep domain expertise allows Simtra to manage everything from high-tech, complex molecules to traditional small molecules with the same level of care and precision.

At the heart of Simtra's competitive advantage is its integrated CDMO model, which Kennedy argues reduces program risk at multiple stages. The approach begins with intentional product design, ensuring the right formulation, lifecycle strategy, and vial selection come together for success. A unified scientific development and manufacturing team works collaboratively throughout the project lifecycle, maintaining continuity of communication and knowledge transfer from early stages through commercialization. Each program is guided by a single project manager, ensuring clear understanding of needs and consistent communication across all functional teams.

Kennedy also highlights Simtra's recent major facility investments, particularly in Bloomington, Indiana, where a new 300,000-square-foot facility introduces high-potency manufacturing capabilities to the United States. This expansion reflects Simtra's responsiveness to customer demand and its commitment to offering dedicated solutions with the flexibility to adapt to evolving project needs. For biotech and pharmaceutical manufacturers seeking a CDMO partner that combines specialized expertise with integrated operations and long-term commitment, Simtra's model offers both technical confidence and operational continuity.